Triple-blind randomized clinical trial was done on 98 hypertensive women of postmenopausal
ages in 2019. The study was executed for 8 weeks with close follow up and , 24-hour
Ambulatory blood pressure monitoring (ABPM) was used to record the initial and final blood
pressures of all participants. Patients were randomized to calcium-D supplement and placebo